Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF

NCT: NCT07429214 · RECRUITING

NCT IDNCT07429214
StatusRECRUITING
Start Date2026-03-23
Completion2026-12-30
SponsorBiosense Webster, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The main purpose of this clinical study is to investigate the effectiveness workflow of the clinical use of the pulsed field (PF) ablation system (VARIPULSE™ Catheter and TRUPULSE™ Generator) when used for cardiac ablation with the new VARIPULSE™ Pro software in participants with paroxysmal atrial fibrillation (PAF; irregular heartbeat where episodes start and stop on their own, usually within seven days) and persistent atrial fibrillation (PsAF; irregular, rapid heartbeat that lasts over 7 days up to 1year and doesn't stop on its own).

Frequently Asked Questions

What is A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF?

A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF is a clinical trial registered under NCT07429214. Current status: RECRUITING.

What is the status of NCT07429214?

The current status of NCT07429214 (A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF) is: RECRUITING.

When did A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF start?

A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF started on 2026-03-23.

Related Devices

PMA P210027Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillationBiosense Webster, Inc. PMA P240006Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible ElectroporationBiosense Webster, Inc. PMA P010068catheter, percutaneous, cardiac ablation, for treatment of atrial flutterBiosense Webster, Inc. PMA P030031catheter, percutaneous, cardiac ablation, for treatment of atrial flutterBiosense Webster, Inc. PMA P040036Cardiac ablation percutaneous catheterBiosense Webster, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑